CDC73 and pachyonychia congenita: Histopathological confirmation of PC needs the presence of unequivocal perineural, lymphatic, or vascular invasion as minimal criteria and can be assisted by biomarkers such as galectin-3 increased expression or loss of nuclear parafibromin immunoreactivity [17,74].